Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06412900
Other study ID # 31347039
Secondary ID 660399
Status Not yet recruiting
Phase
First received
Last updated
Start date May 15, 2024
Est. completion date March 28, 2028

Study information

Verified date May 2024
Source Oslo University Hospital
Contact Peter M. Lauritzen, MD, PhD
Phone +4795248249
Email petlau@ous-hf.no
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Kidney stone disease causes significant morbidity, and stones obstructing the ureter can have serious consequences. Imaging diagnostics with computed tomography (CT) are crucial for diagnosis, treatment selection, and follow-up. Segmentation of CT images can provide objective data on stone burden and signs of obstruction. Artificial intelligence (AI) can automate such segmentation but can also be used for the diagnosis of stone disease and obstruction. In this project, the aim is to investigate if: Manual segmentation of CT scans can provide more accurate information about kidney stone disease compared to conventional interpretation. AI segmentation yields valid results compared to manual segmentation. AI can detect ureteral stones and obstruction or predict spontaneous passage.


Description:

Background: Goals and Objectives: The project aims to contribute to personalized and improved treatment and follow-up of patients with kidney stones using radiomics and the development of an artificial intelligence tool for CT examination assessment. The objectives are to assess: - Whether manual segmentation of CT images of the urinary tract provides equivalent or more accurate information about kidney stone disease compared to conventional interpretation and reporting. - Whether segmentation performed with AI yields valid results compared to manual segmentation. - Whether AI can detect ureteral stones and obstruction and/or predict spontaneous passage of stones. Method: Cohort: Patients are recruited to the study at Oslo University Hospital, Radiology Department, Section Aker, which performs approximately 1350 CT examinations for urinary tract stones in approximately 1000 patients each year. Approximately 500 patients with a new episode or newly occurring colic pain and clinical suspicion of kidney stones are expected to be included. Clinical data (where available): - Baseline CT: date and image data - Initial treatment (conservative, URS, PCN, ESWL) decision after baseline CT - Follow-up CT: date and image data - Time to spontaneous stone passage (negative control CT) or completed surgical intervention (URS) - Any other surgical/invasive procedure - Stone chemical analysis - Clinical biochemistry: creatinine/eGFR, CRP, leukocytes (at baseline and follow-ups). Image data: Clinical radiology report: - Stone: (largest calculus and any obstructing calculus): largest diameter in any plane, density (ROI set by clinical judgment, largest possible ROI - in the slice where the stone is largest), location (upper ureter: above crossing of vessels, lower ureter: below crossing of vessels, ostial: in bladder wall) - Renal pelvis: largest diameter of calyx neck lower calyx, clinical assessment of dilation (not dilated/slight/moderate/severe). - Segmentation: - Stone: total segmented stone volume, largest diameter, and density of segmented stone. - Collecting system: total segmented volume of the collecting system and renal pelvis.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 500
Est. completion date March 28, 2028
Est. primary completion date November 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Referral for CT due to episode of renal colic and clinical suspicion of urinary stone disease or - Referral for CT due to new episode of pain in patient with known urinary stone disease - Age = 18 years Exclusion Criteria: - Referral for control CT of asymptomatic patients with known urinary stone disease - Referral for control CT after treatment - Referral for control CT for spontaneous passage of stone. - Lack of informed consent for any reason.

Study Design


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of stone diameter from manual segmentation with radiology report Stone diameter (in mm) compared between manual segmentation and radiology report (paired t-test or wilcoxon rank sum test if non-normally distributed data) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Primary Comparison of AI-segmentation of stones (DICE-score) with manual segmentation DICE-score for AI-segmentation of stones, compared to manual segmenation (gold standard) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Primary Prospective performance (diagnostic accuracy) of AI detection of ureteral stone (compared to radiology report (gold standard) Comparison of differences in dicotomous proportions in paired data according to Newcombe At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of stone density from manual segmentation with radiology report Stone density (in Hounsfield Units) compared between manual segmentation and radiology report (paired t-test or wilcoxon rank sum test if non-normally distributed data) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of distention of renal pelvis from manual segmentation with radiology report Distention of renal pelvis (in mm) compared between manual segmentation and radiology report (paired t-test or wilcoxon rank sum test if non-normally distributed data) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of AI-segmentation of stones (Hausdorff distance) with manual segmentation Haussdorff distance for AI-segmentation of stones, compared to manual segmenation (gold standard) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of AI-segmentation of stones (diagnostic accuracy) with manual segmentation Diagnostic accuracy for AI-segmentation of stones compared to manual segmenation (gold standard) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of AI-segmentation of renal pelvis (Dice-score) with manual segmentation DICE-score for AI-segmentation of renal pelvis compared to manual segmenation (gold standard) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of AI-segmentation of renal pelvis (Hausdorff distance) with manual segmentation Hausdorff distance for AI-segmentation of renal pelvis compared to manual segmenation (gold standard) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of AI-segmentation of renal pelvis (diagnostic accuracy) with manual segmentation Diagnostic accuracy for AI-segmentation of renal pelvis compared to manual segmenation (gold standard) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of AI-segmentation of renal parenchyma (DICE-score) with manual segmentation DICE-score for AI-segmentation of renal parenchyma compared to manual segmenation (gold standard) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of AI-segmentation of renal parenchyma (Hausdorff distance) with manual segmentation Hausdorff distance for AI-segmentation of renal parenchyma compared to manual segmenation (gold standard) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Comparison of AI-segmentation of renal parenchyma (diagnostic accuracy) with manual segmentation Diagnostic accuracy for AI-segmentation of renal parenchyma compared to manual segmenation (gold standard) At time of CT examination (inclusion and follow up - expected average 12 weeks)
Secondary Prospective performance (diagnostic accuracy) of AI detection of ureteral obstruction (compared to radiology report (gold standard) Comparison of differences in dicotomous proportions in paired data according to Newcombe At time of CT examination (inclusion and follow up - expected average 12 weeks)
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04746378 - PRedictive Accuracy of Initial Stone Burden Evaluation.
Recruiting NCT05100017 - Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure N/A
Recruiting NCT04021381 - Citrate Salts for Stone-free Result After Flexible Ureterorenoscopy for Inferior Calyx Calculi Phase 3
Completed NCT02266381 - A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy N/A
Completed NCT01451931 - Study of Tomography of Nephrolithiasis Evaluation Phase 4
Terminated NCT01431378 - Pilot Study of Model Based Iterative Reconstruction Using 64-Slice N/A
Completed NCT01295879 - Vitamin D Repletion in Stone Formers With Hypercalciuria Phase 4
Completed NCT02895711 - Radiation Dose of Pediatric Patients During Ureteroscopy
Completed NCT05340075 - Staged Bilateral Percutaneous Nephrolithotomy
Recruiting NCT03919227 - Measurement of Resistance During UAS Insertion Procedure in RIRS N/A
Recruiting NCT03717285 - Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS N/A
Completed NCT05340088 - Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
Completed NCT05032287 - Medical Expulsive Therapy Post-SWL For Renal Stones N/A
Recruiting NCT05701098 - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) N/A
Not yet recruiting NCT04080973 - Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia N/A
Terminated NCT01736358 - The Use of Intranasal Ketoralac for Pain Management (Sprix) Phase 4
Completed NCT01792765 - Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach N/A
Completed NCT06211842 - Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study
Not yet recruiting NCT02214836 - Ultrasound Imaging of Kidney Stones and Lithotripsy N/A
Not yet recruiting NCT04606758 - Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease N/A